(Philadelphia, PA) - Glossolalia, otherwise referred
to as “speaking in tongues,” has been around for thousands
of years, and references to it can be found in the Old and New Testament.
Speaking in tongues is an unusual mental state associated with specific
religious traditions. The individual appears to be speaking in an
incomprehensible language, yet perceives it to have great personal
meaning. Now, in a first of its kind study, scientists are shining
the light on this mysterious practice -- attempting to explain what
actually happens physiologically to the brain of someone while speaking
at the University of Pennsylvania School of Medicine
have discovered decreased activity in the frontal lobes, an area
of the brain associated with being in control of one’s self.
This pioneering study, involving functional imaging of the brain
while subjects were speaking in tongues, is in the November issue
of Psychiatry Research: Neuroimaging, the official publication
of the International Society for Neuroimaging in Psychiatry.
Radiology investigators observed increased or decreased brain activity
- by measuring regional cerebral blood flow with SPECT (Single Photon
Emission Computed Tomography) imaging - while the subjects were
speaking in tongues. They then compared the imaging to what happened
to the brain while the subjects sang gospel music.
“We noticed a number of changes that occurred functionally
in the brain,” comments Principal Investigator Andrew
Newberg, MD, Associate Professor of Radiology, Psychiatry,
and Religious Studies, and Director for the Center for Spirituality
and the Mind, at Penn. “Our finding of decreased activity
in the frontal lobes during the practice of speaking in tongues
is fascinating because these subjects truly believe that the spirit
of God is moving through them and controlling them to speak. Our
brain imaging research shows us that these subjects are not in control
of the usual language centers during this activity, which is consistent
with their description of a lack of intentional control while speaking
Newberg went on to explain, “These findings could be interpreted
as the subject’s sense of self being taken over by something
else. We, scientifically, assume it’s being taken over by
another part of the brain, but we couldn’t see, in this imaging
study, where this took place. We believe this is the first scientific
imaging study evaluating changes in cerebral activity -- looking
at what actually happens to the brain -- when someone is speaking
in tongues. This study also showed a number of other changes in
the brain, including those areas involved in emotions and establishing
our sense of self.”
Newberg concludes that the changes in the brain during speaking
in tongues reflect a complex pattern of brain activity. Newberg
suggests that since this is the first study to explore this, future
studies will be needed to confirm these findings in an attempt to
demystify this fascinating religious phenomenon.
This preliminary study, done only at Penn, examined five subjects
in a laboratory setting. The study, set for publication in the November
issue of Psychiatry Research: Neuroimaging, can now be
accessed on-line at www.sciencedirect.com.
The article is titled, “The Measurement of Regional Cerebral
Blood Flow During Glossolalia: a Preliminary SPECT Study.”
Co-authors include: Nancy Wintering, Donna Morgan, and Mark Waldman.
PENN Medicine is a $2.9 billion enterprise
dedicated to the related missions of medical education, biomedical
research, and high-quality patient care. PENN Medicine consists
of the University of Pennsylvania School of Medicine (founded in
1765 as the nation's first medical school) and the University of
Pennsylvania Health System.
Penn's School of Medicine is ranked #2 in the nation for receipt
of NIH research funds; and ranked #3 in the nation in U.S.News &
World Report's most recent ranking of top research-oriented medical
schools. Supporting 1,400 fulltime faculty and 700 students, the
School of Medicine is recognized worldwide for its superior education
and training of the next generation of physician-scientists and
leaders of academic medicine.
The University of Pennsylvania Health System includes three
hospitals, all of which have received numerous national patient-care
honors [Hospital of theUniversity of Pennsylvania; Pennsylvania
Hospital, the nation's first hospital; and Penn Presbyterian Medical
Center]; a faculty practice plan; a primary-care provider network;
two multispecialty satellite facilities; and home care and hospice.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $8.9 billion enterprise.
The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $496 million awarded in the 2020 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is powered by a talented and dedicated workforce of more than 44,000 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2020, Penn Medicine provided more than $563 million to benefit our community.